国家基本药物质量信息平台建设可行性研究  

Feasibility Study of Information Platform Construction of National Essential Medicine Quality

作　　者：李秀记[1] 孙承媛[2] 董中平[1] 于继江[1] 崔晓姣[1] 

机构地区：[1]中国食品药品检定研究院,北京100050 [2]军事医学科学院

出　　处：《中国药事》2013年第7期745-748,共4页Chinese Pharmaceutical Affairs

摘　　要：目的研究探讨我国基本药物质量信息平台建设的可行性。方法对我国当前药品质量信息化建设现状进行调查研究,密切结合基本药物质量现状和我国药品技术监督、行政监督的特点,分析建设国家基本药物质量信息平台的必要性、可行性。结果与结论先进、科学的国家基本药物质量信息平台将为提高基本药物监管水平、确保基本药物质量提供坚强的技术支撑。Objective To discuss the feasibility of information platform construction of national essential medicine quality in China. Methods By analyzing the current development of Chinese essential medicines informatization, with close attention to essential drug quality status, and characteristics of drug technical administration and executive administration in our nation, the feasibility and necessity of building an information platform of national essential medicine quality was discussed. Results and Conclusion An advanced, scientific information platform of national essential medicine quality will provide a solid technical support for improving essential drug administration and ensuring essential drug quality.

关 键 词：基本药物 质量信息 信息平台 

分 类 号：R97[医药卫生—药品] TP393[医药卫生—药学]